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1. Introduction 
Gastroesophageal reflux disease (GERD) is one of acid-related gastrointestinal disorders, 
because GERD develops when excessively acidic gastric contents reflux into the esophagus. 
The condition is believed mainly to be due to an increase in the number of transient LES 
relaxations. Other major mechanisms include decreased clearance of esophageal contents 
and reflux owing to impaired peristalsis, decreased gastric emptying with resultant reflux 
into the esophagus, and increased gastric acid production with a resultant increase in the 
potency of the reflux. Chronic renal failure (CRF) is associated with an increased incidence 
of acid-related gastrointestinal disorders (1-3). Therefore we can predict high morbidity of 
GERD in CRF patients, but the association between GERD and CRF remains unclear.  
In our study (4) by questionnaire for the diagnosis of reflux disease (QUEST) produced by 
Carlsson et al. (5), the prevalence of GERD was 24.2% in the 418 stable hemodialysis (HD) 
patients who did not undergo endoscopic examination. Compared to the reported 
prevalence of GERD in 6010 Japanese adults (16.3%) (6), the prevalence of GERD in CRF 
patients who underwent HD (24.2%) was increased.  
In the gastroendoscopic findings of the 156 CRF patients who underwent endoscopic 
examination, the prevalence of GERD was 34.0%. Especially, in symptomatic cases, the 
prevalence of GERD was 44.0% (7). 
Although we are now aware of the increasing prevalence of symptomatic GERD in HD 
patients, little is known about the gastroendoscopic findings and the prevalence of 
endoscopical GERD in CRF patients. In this chapter, I would like to explain about GERD in 
CRF patients. 
2. Epidemiology 
The overall proportion of reflux esophagitis in 6010 Japanese adults was 16.3% in 
prospective evaluation by gastroendoscopy (6). Several studies using endoscopic 
examination suggested that the overall prevalence of reflux esophagitis in Western countries 
was around 10%-20% (8, 9). These data indicated that reflux esophagitis is a common 
disease in Japan.  
2.1 Evaluation by QUEST  
We examined 418 stable CRF patients (257 men [62%] and 161 women [38%], mean age: 64.9 
± 10.2 [± standard deviation, SD] [range: 23-91] years) who underwent HD in the HD clinics 
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and did not necessarily undergo gastroendoscopy (Table 1) (4). Instead of gastroendoscopy, 
QUEST, a structured questionnaire for the assessment of symptomatic GERD, was used to 
diagnose GERD in this study. We diagnosed GERD in those with a score of four points or 
more. In these 418 stable HD patients, the prevalence of GERD was 101 patients (24.2%) 
(Table 1) (4). Compared to the reported prevalence of GERD in Japan (16.3%) (6), the 
prevalence of GERD in CRF patients (24.2%), especially who underwent HD, is increased. 
This increased prevalence of GERD in HD patients was in accordance with the results (36%) 
of the autopsy study of 78 HD patients (10). 
We also examined the risk factor for GERD in HD patients by using a questionnaire added 
to QUEST (4). The questionnaire included questions about age, sex, BMI (height and 
weight), presence of upper gastrointestinal symptoms, etiology of renal disease, past 
history, alcohol consumption and smoking habits. And we checked medications, laboratory 
data (BUN, Cr, K, Ca, P, TP, Hb, Ht), blood pressure (BP) and cardiothoracic ratio (CTR). As 
for these clinical findings, we compared the GERD group with the non-GERD group. Mean 
age was 62.2 ± 11.4 (± SD) years (range: 35-85) in GERD group and 65.8 ± 12.2 (± SD) years 
(range: 23-91) in non-GERD group. GERD group consisted of 64 males (63%) and 37 females 
(37%), on the other hand non-GERD group consisted of 193 males (61%) and 124 females 
(39%). Mean BMI was 20.8 ± 5.6 (± SD) (range: 14.7-28.2) in GERD group and 20.7 ± 6.2 (± 
SD) (range: 14.1-30) in non-GERD group. 79 patients (18.9%) were smoker, 51% of those 
were GERD group. 91 patients (22.1%) were alcohol drinker, 54% of those were GERD 
group. Diabetic nephropathy was seen in total 120 patients (29.2%) who consisted of 28 
GERD patients (27%) and 92 non-GERD patients(29%). Mean CTR was 51.2 ± 10.1 (± SD) 
(range: 40.5-61.8) in GERD group and 51.9 ± 10.6 (± SD) (range: 39.5-77.6) in non-GERD 
group. Mean systolic BP was 158.5 ± 16.2 (± SD) (range: 120-210) in GERD group and 155.7 ± 
15.8 (± SD) (range: 90-230) in non-GERD group. Mean diastolic BP was 78.6 ± 12.1 (± SD) 
(range: 55-110) in GERD group and 78.6 ± 12.5 (± SD) (range: 45-110) in non-GERD group. 
There were no statistically significant differences in age, sex, BMI, alcohol consumption, 
smoking, etiology of CRF, CTR, BP, laboratory data and medications between the GERD 
group and non-GERD group (Table 2, Fig. 1, 2). 
The risk factor for this increased GERD in CRF patients was not clear. Evaluation of the 
prevalence of reflux esophagitis of HD patients needs further exploration by endoscopy. 
2.2 Evaluation by endoscopic examination 
In an endoscopic surveillance study in adults, no difference was seen in the incidence of 
esophagitis between patients with CRF and healthy controls (11). On the other hand, in an 
uncontrolled study using 24 hour pH-metry, Ruley et al found that 73% (16 of 22) of 
children with CRF had significant GERD.  
We examined 156 CRF patients (97 men [62%] and 59 women [38%], mean age: 64.2 ± 12.3 [± 
SD] [range: 29-89] years) whose creatinine level was more than 2 mg/dl and who 
underwent endoscopy examination (7). This group involved 42 patients (27%) with some 
upper GI symptoms, 55 patients (35%) with DM and 87 patients (56%) with HT (Table 3). To 
investigate renal function, we classified the patients into three categories based on the 
creatinine level and as follows: 2< Cr. < 5 (44 patients [28%]), Cr. 5< and patients on pre-
dialysis (53 patients [34%]), Cr. 5< and patients on hemodialysis (59 patients [38%]) (Table 
3). As we could not examine glomerular filtration rate (GFR) of all patients, we used serum 
creatinine level as renal function. These clinical findings were compared with the 
gastroendoscopic findings retrospectively. The prevalence of GERD was highest (53 patients 
 
www.intechopen.com
 
Gastroesophageal Reflux Disease in Chronic Renal Failure Patients 
 
3 
Patients (n = 418)
Mean age (years)                                         
Sex
Male                                                        
Female                                                     
BMI                                                          
Smoker                                                        
Alcohol Drinker                                          
QUEST score (more than 4)                       
Etiology of Renal Disease  
Chronic Glomerulonephritis
Diabetic Nephropathy                           
Nephrosclerosis
Polycystic Kidney                       
Others                                         
64.9 ± 10.2 (range: 23-91)
257 (61.5%)
161 (38.5%)
20.7 ± 5.9 (range: 14.1-30.0)
79 (18.9%)
91 (22.1%)
101 (24.2%)
121 (29.4%)
120 (29.2%)
75 (18.2%)
24 (5.8%)
71 (17.3%)
Data are given as the mean ± standard deviation (SD) or as the number of patients (n)  
Table 1. Clinical characteristics of 418 Stable HD Patients. 
 
GERD Group (n = 101)        Non-GERD Group (n=317)
Mean age (years)                               
Sex
Male                                                        
Female                                                      
Mean Body Mass Index            
Smoker                                                          
Alcohol Drinker                                            
Prevalence of 
Diabetes mellitus                                         
Mean Cardiothoracic            
Ratio (%)                                 
Mean Blood Pressure
Systolic (mmHg)                 
Diastolic (mmHg)                  
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS, not significant 
62.2 ± 11.4 (range: 35-85)
64 (63%)
37 (37%)
20.8 ± 5.6 (range: 14.7-28.2)
40 (51%)
49 (54%)
27 (27%)
51.2 ± 10.1 (range: 40.5-61.8)
158.5 ± 16.2 (range: 120-210)
78.6 ± 12.1 (range: 55-110)
65.8 ± 12.2 (range: 23-91)
193 (61%)
124 (39%)
20.7 ± 6.2 (range: 14.1-30.0)
39 (49%)
42 (46%)
92 (29%)
51.9 ± 10.6 (range: 39.5-77.6)
155.7 ± 15.8 (range: 90-230)
78.6 ± 12.5 (range: 45-110)
Data are given as the mean ± standard deviation (SD) or as the number of patients (n)
 
Table 2. Comparison between GERD Group and Non-GERD Group in 418 Stable CRF 
Patients. 
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Fig. 1. Comparison of laboratory data between GERD group and non-GERD group. 
 
 
 
 
Fig. 2. Comparison of medications between GERD group and non-GERD group. 
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[34.0%]) in the gastroendoscopic findings of the 156 CRF patients who underwent 
endoscopic examination (Fig.3). Gastric ulcer and ulcer scar, erosion, hemorrhagic change 
(hematin), angiodysplasia and gastric antral vascular ectasia (GAVE) were seen in 39 
patients (25%), 42 patients (27%), 41 patients (26%), 8 patients (5%) and 5 patients (3%), 
respectively (Fig.3). In the evaluation of 42 patients (27%) with some upper GI symptoms, 22 
patients (52%) underwent hemodialysis, and the prevalence of GERD was highest (18 
patients [44.0%]) in the gastroendoscopic findings. And in relationships between renal 
function and gastrointestinal symptoms, as renal function became worse, symptomatic cases 
tended to increase. There were statistically significant differences between the patients on 
hemodialysis and pre-dialysis (Fig.4). In relationships between renal function and 
gastroendoscopic findings, in the patients on hemodialysis the frequency of GERD and 
erosion increased, especially the prevalence of GERD was highest (50.0%). There were 
statistically significant differences between the patients on hemodialysis and pre-dialysis 
(Fig.5). The severity of GERD tended to be mild. In the patients with GERD, 77% was grade 
M or A of modified Los Angels grading system. Esophageal herniation was seen in 19 
patients (32%) (Fig.6). 
Although mechanisms exist that potentially lead to an increase of GERD in CRF, their 
existence would be insufficient to suggest that the incidence of GERD is increased in CRF 
patients without further study. 
 
 
 
 
 
Patients (n = 156)
Mean age (years)                                         
Sex
Male                                                        
Female                                                     
Cases with Upper GI Symptoms                 
Renal function
2 < Cr. < 5                                               
Cr. 5 < , without hemodialysis
Cr. 5 < , with hemodialysis
Complications
Diabetes Mellitus                                    
Hypertension                                           
64.2 ± 12.3 (range: 29-89)
97
59
42
44
53
59
55
87
Data are given as the mean ± standard deviation (SD) or as the number of patients (n)  
 
 
 
Table 3. Clinical characteristics of 156 CRF patients. 
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Fig. 3. Gastroendoscopic findings of 156 CRF patients who underwent endoscopic 
examination. 
 
 
Fig. 4. Relationships between renal function and gastrointestinal symptoms. 
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Fig. 5. Relationships between renal function and gastroendoscopic findings. 
 
        
Fig. 6. Relationships between severity of GERD and esophageal herniation. 
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3. Pathophysiology 
The pathophysiology of GERD is multifactorial and depends on interaction between 
aggressive factors and defensive factors. It is believed mainly that the aggressive factor is an 
increased gastric acid production and the defensive factor is a decreased gastric emptying. 
3.1 Aggressive factors 
3.1.1 Hypergastrinemia  
We have to consider the association of CRF with an increased gastric acid production as an 
aggressive factor. Although we cannot say that increased acid production occurs in all CRF 
patients, some patients certainly have increase acid production. Hypergastrinemia is in fact 
present (12, 13) in CRF patients, and higher acid production can occur secondary to 
hypergastrinemia, which can be a consequence of decreased clearance of gastrin owing to a 
reduced glomerular filtration rate (GFR). And Straathof et al. reported that postprandial 
plasma concentrations of gastrin decrease lower esophageal sphincter pressure and increase 
the transient lower esophageal sphincter relaxations associated with reflux (14). In our 
study, the prevalence of GERD tended to increase as renal function become worse, although 
we could not examine serum gastrin level (7). But hypergastrinemia may also be in part to 
due increased secretion, because the density of G cells is increased in CRF patients (15, 16) 
possibly owing to a hyperthyroid state. Elevated serum gastrin causes an increase in acid 
production by the parietal cells. However, when measured in CRF patients, large variations 
in the mean gastric acid production actually occur from achlorhydria to hyperchlorhydria 
(17). Indeed, achlorhydria has been suggested as the stimulus for hypergastrinemia, because 
a feedback mechanism exists between the G cells and the low-acid state that stimulates the 
secretion of gastrin.  
Serum gastrin may be an important factor as both an aggressive and a defensive factor.  
3.1.2 Helicobacter pylori infection 
On the other hand several studies have shown that rates of Helicobacter pylori (H. pylori) 
infection in CRF are lower than expected (17-20). Shousha et al. found that the prevalence of 
antral H. pylori was significantly less in patients with renal disease (24%) than in a control 
group (42%) (19). These lower rates of H. pylori, which lead to hyperacidity state in stomach, 
may potentially be a mechanism by which CRF can be associated with GERD. H. pylori 
infection also may be an important factor for GERD. 
Some researchers reported that long-term dialysis reduced the prevalence of H. pylori 
infection (21–23), while others found no such correlation (24, 25). Nakajima et al. (22) 
reported that in Japanese patients on HD the mean duration of HD was significantly longer 
in H. pylori-negative patients than in H. pylori-positive patients. More recently, Sugimoto et 
al. (23) have shown that the prevalence of H. pylori infection serially decreased within 4 
years in identical patients on HD, particularly among patients on HD for less than 4 years. 
Moriyama et al. (26) reported that such an inverse association between H. pylori and HD was 
again confirmed, and such a trend was obvious in patients on HD for more than 8 years. 
It is widely accepted that reflux esophagitis is associated with H. pylori infection in the 
general population (27, 28). However, only two studies have investigated the correlation 
between H. pylori infection and reflux esophagitis in patients with CRF (29, 30). In a case–
control study by Cekin et al. (30), H. pylori infection was found to be protective against 
reflux esophagitis in patients on HD; in contrast, in another study of patients prior to renal 
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transplantation, reflux esophagitis was found irrespective H. pylori infection (29). These 
results suggest that long-term HD is an independent risk factor of reflux esophagitis.  
3.2 Defensive factors 
Then we also have to consider the association of CRF with a decreased gastric emptying as a 
defensive factor. Nausea and vomiting are often encountered in CRF and can be caused by 
delayed gastric emptying. The association of CRF with delayed gastric emptying seems to 
depend on the type of patient. A patient on peritoneal dialysis would be expected to have 
delayed gastric emptying simply due to the physical impairment caused by the peritoneal 
fluid. A lot of CRF patients have DM and HT as complications. We can also predict 
decreased gastric emptying by DM neuropathy and LES relaxations by Ca-antagonists and 
nitrites. CRF patients in our study also involved 55 patients (35%) with DM and 87 patients 
(56%) with HT, although we could not show the association of GERD with DM or HT (4). 
Results in other CRF patients, such as patients with uremia but not on dialysis, or patients 
on HD, have yielded conflicting results. Three studies demonstrated delayed gastric 
emptying in uremic predialysis patients (31-33). The researchers have also documented 
delayed gastric emptying in hemodialysis patients particularly patients who are 
hypoalbuminemic (32, 33). In our study, as for total protein, the differences between GERD 
group and Non-GERD group were not statistically significant (Fig. 1) (4). The situation is 
meddled by other studies that have not demonstrated decreased gastric emptying in 
hemodialysis patients (33-36). 
The reasons for the discrepancy between the various results are likely multifactorial. One of 
the confounding factors is whether the patient is pre-dialysis, on peritoneal dialysis, or on 
hemodialysis. Ko et al demonstrated that uremic patients undergoing dialysis had gastric 
rhythm disturbance that deteriorated after HD (37). Dumitrascu et al demonstrated that 
patients with CRF had delayed gastric emptying if parasympathetic and sympathetic 
neuropathy were both present (38). DM is at increased risk of autonomic neuropathy, and 
they certainly constitute a large proportion of patients with CRF. In our study diabetic 
nephropathy was 29.2% of 418 stable HD patients (Table 1) and the differences between 
GERD group and Non-GERD group were not statistically significant (Fig. 1) (4). As the other 
risk factor of GERD, we examined age, sex, BMI, alcohol, smoking, etiology of renal disease, 
laboratory data (BUN, Cr., K, Ca, P, TP, Ht, Hb) and some medications, but the differences 
between GERD group and Non-GERD group were not statistically significant (Fig. 1, 2) (4). 
4. Conclusions 
CRF, especially HD patients, seem to be associated with an increased incidence of GERD, 
though the pathophysiology of GERD is multifactorial and complicated. We should keep 
GERD in mind, when we see CRF patients. 
We used QUEST or endoscopy for the diagnosis of GERD. Though endoscopy is highly 
useful for the diagnosis of reflux esophagitis, endoscopic examination has not been used to 
evaluate the prevalence of reflux esophagitis in a large population of HD patients. Because 
many HD patients have the other diseases, we cannot undergo endoscopy easily. QUEST is 
thought to be accurate since upper GI symptoms in HD are correlated well with GERD (39). 
And we think that GERD diagnosed by QUEST is nearly equal to symptomatic GERD. But 
we need to pay attention that symptomatic GERD is not always equal to endoscopic GERD.  
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